The initiative was founded in 2015, by Dr. Priscilla Chan and her spouse Mark Zuckerberg, the co-founder and CEO of Facebook.
Prior to the acquisition, Brainlab had been an investor and distribution partner for Medineering for nearly three years.
The story of Theranos and its CEO Elizabeth Holmes is wrought with alleged fraud, betrayal, lawsuits, a secret romance, and jumpy houses. Yes, we said jumpy houses. Here are seven times HBO's documentary, The Inventor: Out for Blood in Silicon Valley blew our minds.
Data from the UK’s National Health Service EndoBarrier Service show a significant reduction in HbA1c, weight, liver fat, and cardiovascular disease risks as well as a reduction in the need for insulin in some patients.
The Cupertino, CA-based company released preliminary data from the Apple Heart Study, which demonstrates the effectiveness of wearables to detect atrial fibrillation.
The Abbott Park, IL-based company’s expanded indication would allow the MitraClip to address the secondary form of mitral regurgitation and would significantly increase the amount of people with MR able to be treated by the device.
The Kalamazoo, MI-based company is expected to pay $110 million up front, plus an additional $110 million in milestones to pick up OrthoSpace.
Watchman has been a significant driver for Boston Scientific and is expected to have strong growth this year as well.
Norman Sharpless, director of the National Cancer Institute, will become “acting” commissioner of FDA after commissioner Scott Gottlieb abruptly announced he is leaving the position.
As the Irvine, CA-based company strengthens its mitral valve portfolio, it also faces a lawsuit from Abbott Laboratories over the Pascal system.
The agency released a letter to healthcare providers pointing out the risks and said it would hold a public advisory committee meeting.